Feeds

Two drug trial victims released

But one still critical

Intelligent flash storage arrays

Doctors caring for the six human guinea pig victims of the disastrous TeGenero drug trial have discharged two of the men. Three others remain as in-patients at Northwick Park Hospital, London, while one man is still in a critical condition after being administered an experimental immune treatment more than two weeks ago.

The hospital is staying tight-lipped on the prognosis for the critical patient, but says he has shown some signs of improvement. The released volunteers will continue to receive treatment and be monitored as out-patients.

The men were given TGN1412, an antibody designed to suppress the destructive power of immune cells in diseases like rheumatoid arthritis and leukaemia. The problems didn't show up in animal trials.

Speculations about what caused the reaction have centred on contamination of the doses by bacterial toxins, and a paradoxical super-activation of the volunteer's immune system.®

Choosing a cloud hosting partner with confidence

More from The Register

next story
SECRET U.S. 'SPACE WARPLANE' set to return from SPY MISSION
Robot minishuttle X-37B returns after almost 2 years in orbit
LOHAN crash lands on CNN
Overflies Die Welt en route to lively US news vid
'Utter killjoy Reg hacks have NEVER BEEN LAID', writes a fan
'Shuddit, smarty pants!' Some readers reacted badly to our last Doctor Who review ...
Experts brand LOHAN's squeaky-clean box
Phytosanitary treatment renders Vulture 2 crate fit for export
Carry On Cosmonaut: Willful Child is a poor taste Star Trek parody
Cringeworthy, crude and crass jokes abound in Steven Erikson’s sci-fi debut
White LED lies: It's great, but Nobel physics prize-winning great?
How artificial lighting could offer an artificial promise
Origins of SEXUAL INTERCOURSE fished out of SCOTTISH LAKE
Fossil find proves it first happened 385 million years ago
prev story

Whitepapers

Forging a new future with identity relationship management
Learn about ForgeRock's next generation IRM platform and how it is designed to empower CEOS's and enterprises to engage with consumers.
Why cloud backup?
Combining the latest advancements in disk-based backup with secure, integrated, cloud technologies offer organizations fast and assured recovery of their critical enterprise data.
Win a year’s supply of chocolate
There is no techie angle to this competition so we're not going to pretend there is, but everyone loves chocolate so who cares.
High Performance for All
While HPC is not new, it has traditionally been seen as a specialist area – is it now geared up to meet more mainstream requirements?
Intelligent flash storage arrays
Tegile Intelligent Storage Arrays with IntelliFlash helps IT boost storage utilization and effciency while delivering unmatched storage savings and performance.